The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation.
Fiche du document
2000
- doi: 10.1074/jbc.M000482200
- issn: 0021-9258
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1074/jbc.M000482200
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/10807904
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/0021-9258
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_3ED2A05AC91F8
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
B cell differentiation factor-2 Myeloid differentiation-inducing protein Myeloid growth inducer-2 MGI-2 (Biomolecule) Plasmacytoma growth factor Hepatocyte-stimulating factor Hybridoma growth factor B cell stimulation factor-2 IL-6 (Biomolecule) Lymphotoxin TNF (Immunology) Cachectin Genetic transduction Proteids People Man Humanity (Human beings) Human race Mankind Homo sapiens Humankind Humans Immune globulins Antibodies Immune serum globulin IgG Laser cell sorting Cell counting, Laser Flow cytophotometry Laser cell counting Flow cytofluorometry Cell sorting, Laser Cell separation, Laser Laser cell separation Activation, Enzyme JNK protein kinasesCiter ce document
F. Mühlenbeck et al., « The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation. », Serveur académique Lausannois, ID : 10.1074/jbc.M000482200
Métriques
Partage / Export
Résumé
Overexpression of the tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors, TRAIL-R1 and TRAIL-R2, induces apoptosis and activation of NF-kappaB in cultured cells. In this study, we have demonstrated differential signaling capacities by both receptors using either epitope-tagged soluble TRAIL (sTRAIL) or sTRAIL that was cross-linked with a monoclonal antibody. Interestingly, sTRAIL was sufficient for induction of apoptosis only in cell lines that were killed by agonistic TRAIL-R1- and TRAIL-R2-specific IgG preparations. Moreover, in these cell lines interleukin-6 secretion and NF-kappaB activation were induced by cross-linked or non-cross-linked anti-TRAIL, as well as by both receptor-specific IgGs. However, cross-linking of sTRAIL was required for induction of apoptosis in cell lines that only responded to the agonistic anti-TRAIL-R2-IgG. Interestingly, activation of c-Jun N-terminal kinase (JNK) was only observed in response to either cross-linked sTRAIL or anti-TRAIL-R2-IgG even in cell lines where both receptors were capable of signaling apoptosis and NF-kappaB activation. Taken together, our data suggest that TRAIL-R1 responds to either cross-linked or non-cross-linked sTRAIL which signals NF-kappaB activation and apoptosis, whereas TRAIL-R2 signals NF-kappaB activation, apoptosis, and JNK activation only in response to cross-linked TRAIL.